NantHealth, Inc. (NASDAQ:NH) is expected to announce second quarter financial results after market close (confirmed) on December 31, 1969. The company added about -1.5% percent in value since last earnings when it was at $3.44. Based on the most relevant historical data, there is a N/A percent probability for share price to go down following the next earnings report. Looking further into earnings reaction history, the stock had moved down 2 times out of last 3 quarters. It has topped earnings-per-share estimates 50% of the time in its last 12 earnings reports. It missed earnings on 0 occasions, and it has met expectations 1 time.
NantHealth, Inc. (NH) History
Overall, the average earnings surprise was -26.2 percent over the past four quarters. Back on May 10, 2017, it posted earnings per share at $-0.24 which missed the consensus $-0.19 projection (Negative surprise of -23.08%). Revenue came in at $22.51M versus consensus estimate of $29.06M. The stock dropped -2.33% percent the day following the earnings was released, and on 7th day price change was -11.34% percent.
On March 30, 2017, it posted earnings per share at $-0.18 versus the consensus estimate of $-0.19 (Negative surprise of -6.10%). Revenue of $24.08M was below the $27.93M analysts had expected. The stock dropped -2.55% the day following the earnings was released, and on 7th day price change was 6.48%.
On November 07, 2016, it posted earnings per share at $-0.18, topped the consensus estimate of $-0.20 (Negative surprise of -11.76%). Revenue for the quarter was $25.36M while analysts had expected revenues to come in at $26.42M. The stock fell -9.67% the day following the earnings was released, and on 7th day price change was 17.65%.
On August 09, 2016, it posted earnings per share at $-0.15 compared with the consensus estimate of $-0.41 (Negative surprise of -63.86%). That came on revenues of $31.49M for the quarter. Analysts had expected $23.55M in revenue.
NantHealth, Inc. (NH) Expectations
In front of Q3 earnings release, Wall Street is expecting earnings per share of $-0.15. The analysts’ current consensus range is $-0.16-$-0.14 for EPS. The market consensus range for revenue is $29.5M-$35.98M, with an average of $32.22M.
NantHealth, Inc. (NASDAQ:NH) last closed at $4.35, sending the company’s market cap around $502.64M. The consensus 12-month price target from brokerage firms covering the stock is $8.75. The share price has declined -72.46% from its best level in 52 weeks and advanced -56.24% this year. It recently traded in a range of $-$ at a volume of 775,247 shares. The stock ended last trading session with the price nearly 32.62% higher for the last 5 trading days, rebounding 47.96% from its 52-week low.